Sinn P - Search Results

1

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.

Marmé F, Werft W, Walter A, Keller S, Wang X, Benner A, Burwinkel B, Sinn P, Hug S, Sohn C, Bretz N, Moldenhauer G, Rupp C, Rupp AK, Biakhov MY, Bottini A, Friedrichs K, Khailenko VA, Manikhas GM, Ruiz A, Sánchez-Rovira P, Santoro A, Segui MA, Villena C, Lichter P, Kristiansen G, Altevogt P, Schneeweiss A. Marmé F, et al. Among authors: sinn p. Breast Cancer Res Treat. 2012 Apr;132(3):819-31. doi: 10.1007/s10549-011-1759-9. Epub 2011 Sep 30. Breast Cancer Res Treat. 2012. PMID: 21960110 Clinical Trial.

2

Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials.

Marmé F, Aigner J, Lorenzo Bermejo J, Sinn P, Sohn C, Jäger D, Schneeweiss A. Marmé F, et al. Among authors: sinn p. Int J Cancer. 2013 Aug 15;133(4):1006-15. doi: 10.1002/ijc.28094. Epub 2013 Mar 16. Int J Cancer. 2013. PMID: 23400797 Free article. Clinical Trial.

3

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer.

Jauch SF, Riethdorf S, Sprick MR, Schütz F, Schönfisch B, Brucker SY, Deutsch TM, Nees J, Saini M, Becker LM, Burwinkel B, Sinn P, Marmé F, Pantel K, Jäger D, Sohn C, Trumpp A, Wallwiener M, Schneeweiss A. Jauch SF, et al. Among authors: sinn p. Breast Cancer Res Treat. 2019 Jan;173(1):155-165. doi: 10.1007/s10549-018-4972-y. Epub 2018 Oct 1. Breast Cancer Res Treat. 2019. PMID: 30276763

4

FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.

Marmé F, Werft W, Benner A, Burwinkel B, Sinn P, Sohn C, Lichter P, Hahn M, Schneeweiss A. Marmé F, et al. Among authors: sinn p. Ann Oncol. 2010 Aug;21(8):1636-1642. doi: 10.1093/annonc/mdq017. Epub 2010 Feb 10. Ann Oncol. 2010. PMID: 20147743 Free article. Clinical Trial.

5

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.

Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, Smetanay K, Golatta M, Sohn C, Schuetz F, Heil J, Schneeweiss A. Hennigs A, et al. Among authors: sinn p. Breast Cancer Res Treat. 2016 Dec;160(3):491-499. doi: 10.1007/s10549-016-4016-4. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744486 Free PMC article.

6

Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

Heil J, Schaefgen B, Sinn P, Richter H, Harcos A, Gomez C, Stieber A, Hennigs A, Rauch G, Schuetz F, Sohn C, Schneeweiss A, Golatta M. Heil J, et al. Among authors: sinn p. Eur J Cancer. 2016 Dec;69:142-150. doi: 10.1016/j.ejca.2016.09.034. Epub 2016 Nov 4. Eur J Cancer. 2016. PMID: 27821317

7

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

Heil J, Gondos A, Rauch G, Marmé F, Rom J, Golatta M, Junkermann H, Sinn P, Aulmann S, Debus J, Hof H, Schütz F, Brenner H, Sohn C, Schneeweiss A. Heil J, et al. Among authors: sinn p. Breast. 2012 Jun;21(3):303-8. doi: 10.1016/j.breast.2012.01.009. Epub 2012 Feb 5. Breast. 2012. PMID: 22310244 Free article.

8

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.

Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marmé F, Jäger D, Kauczor HU, Stieber A, Lindel K, Debus J, Golatta M, Schütz F, Sohn C, Heil J, Schneeweiss A. Hennigs A, et al. Among authors: sinn p. BMC Cancer. 2016 Sep 15;16(1):734. doi: 10.1186/s12885-016-2766-3. BMC Cancer. 2016. PMID: 27634735 Free PMC article.

9

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.

Walter V, Fischer C, Deutsch TM, Ersing C, Nees J, Schütz F, Fremd C, Grischke EM, Sinn P, Brucker SY, Schneeweiss A, Hartkopf AD, Wallwiener M. Walter V, et al. Among authors: sinn p. Breast Cancer Res Treat. 2020 Aug;183(1):137-144. doi: 10.1007/s10549-020-05746-8. Epub 2020 Jul 1. Breast Cancer Res Treat. 2020. PMID: 32613540 Free PMC article.

10

Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.

Schneeweiss A, Hensel M, Sinn P, Khbeis T, Haas R, Bastert G, Ho AD. Schneeweiss A, et al. Among authors: sinn p. Ann Oncol. 2002 May;13(5):679-88. doi: 10.1093/annonc/mdf168. Ann Oncol. 2002. PMID: 12075735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page